Iron Therapy

Decreased absorption of oral iron leading to iron deficiency is a significant cause of anaemia in patients with gastrointestinal conditions including inflammatory bowel disease (IBD) and following gastric bypass surgery. Although oral iron is often used, reductions in intestinal absorption mean that the effectiveness of such treatment may be limited in these patients. Intravenous iron has been shown to be a safe, effective treatment strategy for overcoming the iron deficiency associated with these conditions, resulting in better outcomes and improved quality of life.

Intravenous iron therapy reduces symptoms for patients with chronic heart failure irrespective of anaemia, according to a subanalysis. The study indicates that iron status should be assessed in symptomatic patients with chronic heart failure both with and without anaemia, and that treatment of iron deficiency should be considered in both patient populations.

The refreshed website is a non-promotional, educational online resource which offers healthcare professionals, from a host of different therapeutic areas, the current and topical information they need to understand and manage iron deficiency effectively.

Ferric carboxymaltose has the same or better efficacy as standard preparations for parenteral iron replacement in patients who have undergone bariatric and gastric surgery, new data indicates. The simple dosing requirements of ferric carboxymaltose make the preparation an attractive option for this patient population, as attendance at follow-up appointments is traditionally poor.


Subscribe to RSS - Iron Therapy